Search Type: drug or dietary supplement name
Search Term: methylphenidate [extended or sustained release] (APTENSIO XR, CONCERTA, DAYTRANA [TRANSDERMAL], METADATE CD, METADATE ER, METHYLIN ER, QUILLICHEW, QUILLIVANT XR, RITALIN LA)


Drug Profiles | Worst Pills, Best Pills Newsletter Articles | Additional Information from Public Citizen

Drug and Dietary Supplement Profiles

A comprehensive review of the safety and effectiveness of this drug. If the drug is not a Do Not Use product, information on adverse effects, drug interactions and how to use the medication are included.
Search results below include drug profiles where your selected drug is a primary subject of discussion

Disease and Drug Family Information

Search results below include Disease and Drug Family Information where your selected drug is a primary subject of discussion
  • Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder [hide all summaries]
    To correctly establish the diagnosis of ADHD requires the use not only of medical but also of special psychological, educational, and social resources. Many children diagnosed with ADHD actually have problems that are primarily caused or worsened by inadequate teachers, unsuitable educational settings, or by problems with their parents. Similarly, many adults diagnosed with ADHD may have interpersonal problems that need to be dealt with by psychotherapy.

Worst Pills, Best Pills Newsletter Articles

Search results below include Worst Pills, Best Pills Newsletter Articles where your selected drug is a primary subject of discussion
  • A Guide to Treatment for ADHD [hide all summaries]
    (October 2016)
    The number of children diagnosed with attention deficit hyperactivity disorder (ADHD) and treated with drugs has increased dramatically over the past decade. Learn the steps needed for an accurate ADHD diagnosis and understand the variety of treatments available before working with your child's doctor on a plan for treatment.
  • News Brief for September 2015 [hide all summaries]
    (September 2015)
    In our news brief this month, we report on a recent FDA safety warning about permanent disfiguring skin color changes caused by a medication patch used for treating attention-deficit hyperactivity disorder.
  • Quality of Drug Prescribing [hide all summaries]
    (March 2011)
    The article reviews a study on the potentially dangerous, inappropriate prescribing of 77 drugs that pose a high risk to older adults. Of the 67 of these drugs that we had previously reviewed in Worst, Pills, Best Pills News, we had classified 60 (90 percent) of them as “Do Not Use,” and the other seven as "Limited Use."
  • Smoke & Mirror Marketing (& Other Clever Big Pharma Tricks) [hide all summaries]
    (May 2010)
    The article reviews 12 prescription drugs, many of which are top-sellers, all of which are greatly overpriced in comparison to older "versions" of the same drugs. The patents on the old drugs expired so the "innovative" companies patented these new products, gaining a patent on them, and, for all practical purposes, using them as a license to print money. There is no evidence that any of the new ones are better than the now less-expensive, old versions.
  • American Heart Association Recommends Screening for Heart Disease in Children Getting Drugs for ADHD [hide all summaries]
    (June 2008)
    The American Heart Association (AHA) has just recommended specific screening for heart problems for children and adolescents before they get stimulant drugs for treating attention deficit hyperactivity disease (ADHD). The recommendations include a thorough history, a physical exam focussing on the heart and, according to the American Heart Association, that it is reasonable to obtain an electrocardiogram. The article lists the components of an adequate history and physical exam to look for the presence of pre-existing heart disease in children.
  • Pharmacists Ordered to Distribute Medication Guides About Serious Heart, Psychiatric Problems Linked to Attention Deficit Drugs [hide all summaries]
    (August 2007)
    Patients currently taking drugs approved for the treatment of ADHD who experience any of the cardiac or psychiatric side effects mentioned in this article are advised to seek medical attention immediately.
  • FDA Issues Stronger Warnings for ADHD Stimulants; Warnings Don’t Go Far Enough [hide all summaries]
    (November 2006)
    If you are considering treatment with a stimulant ADHD drug for yourself or your child, become familiar with the new warnings for these drugs that are presented in this article. The new warnings do not tell patients that the drugs can also cause sudden death in those using the medication properly, not just in those abusing the drugs.

SHOW secondary search results for methylphenidate [extended or sustained release] (APTENSIO XR, CONCERTA, DAYTRANA [TRANSDERMAL], METADATE CD, METADATE ER, METHYLIN ER, QUILLICHEW, QUILLIVANT XR, RITALIN LA)

Copyright © 2017 Public Citizen's Health Research Group. All rights reserved. https://www.worstpills.org/